查看購物車
  • Simplified Chinese
  • English
2030 年歐洲生物分析測試服務市場預測 - 區域分析 - 按服務分類；疾病適應症；和最終用戶
市場調查報告書
商品編碼
1463676

2030 年歐洲生物分析測試服務市場預測 - 區域分析 - 按服務分類；疾病適應症；和最終用戶

Europe Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User
出版日期: | 出版商: The Insight Partners | 英文 117 Pages | 訂單完成後即時交付

價格

2022年歐洲生物分析測試服務市值為13.7448億美元，預計2030年將達到29.5696億美元；預計2022年至2030年複合CAGR為10.0%。

對生物相似藥和生物製劑分析測試的高需求推動了歐洲生物分析測試服務市場

生物製劑是醫藥市場中最有前景的重要治療領域之一。發炎性腸道疾病、癌症和類風濕性關節炎等慢性病病例數量的增加推動了對生物製劑的需求。然而，近年來，生物製劑的高成本已將藥物開發商和醫療保健利益相關者的注意力轉向生物相似藥。此外，生物製劑專利和獨佔期即將到期也為生物相似藥的開發創造了機會。據麥肯錫公司稱，到2025 年，約有19 種大批量生物製劑將失去排他性。緊隨其後。無障礙藥物協會 (AAM) 預計，生物相似藥推出後，品牌生物製劑的平均價格將下降 25% 左右，因為生物相似藥的平均銷售價格比原品牌生物製劑低 50% 左右。

生物相似藥研發的預期成長將增加對相關生物分析測試服務的需求——生物相似藥的兼容性研究、穩定性測試、產品釋放測試和生物相似藥蛋白質分析——以降低藥物開發所涉及的風險。因此，生物相似藥分析測試需求的成長正在推動生物分析測試服務市場的成長。

歐洲生物分析測試服務市場概況

歐洲的生物分析測試服務市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在全球生物分析測試服務市場中佔有重要地位。由於製藥、生物製藥和生物技術行業強大的製造能力，以及歐洲不同國家領先的生物分析測試服務提供商的存在，預計歐洲生物分析測試服務市場在預測期內將顯著成長。

歐洲生物分析測試服務市場收入及 2030 年預測（百萬美元）

歐洲生物分析測試服務市場細分

歐洲生物分析測試服務市場根據測試類型、疾病適應症、最終用戶和國家進行細分。

根據測試類型，歐洲生物分析測試服務市場分為藥物動力學、生物標記、免疫原性、病毒學測試、基於細胞的測定等。 2022 年，基於細胞的檢測領域佔據最大的市場佔有率。

根據疾病適應症，歐洲生物分析檢測服務市場分為心血管、神經系統疾病、代謝性疾病、呼吸道疾病、自體免疫疾病、腫瘤、性健康、骨骼疾病等。 2022 年，腫瘤學領域佔據最大的市場。

根據最終用戶，歐洲生物分析測試服務市場分為製藥和生物製藥公司、合約研究組織（CRO）、合約開發和製造組織（CDMO）等。 2022 年，製藥和生物製藥公司領域佔據最大的市場佔有率。

根據國家/地區，歐洲生物分析測試服務市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國在歐洲生物分析測試服務市場佔有率中佔據主導地位。

SGS SA、康龍化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、KCAS Bioanalytical and Biomarker Services LLC、ICON Plc 和 Intertek Group Plc 等在歐洲生物分析測試服務市場營運的領導公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲生物分析測試服務市場格局

  • 概述
  • PEST分析
    • 歐洲PEST分析

第 5 章：歐洲生物分析測試服務市場 - 主要產業動態

  • 主要市場促進因素：
    • 藥廠增加研發活動外包
    • 對生物相似藥和生物製劑分析測試的高需求
  • 主要市場限制：
    • 生物分析方法開發與驗證的挑戰
  • 主要市場機會
    • 醫藥產業持續成長
  • 未來的趨勢
    • 針對新興罕見疾病的藥物發現和開發活動不斷增加
  • 影響分析：

第 6 章：生物分析測試服務市場 - 歐洲市場分析

  • 生物分析測試服務市場收入，2022 - 2030

第 7 章：歐洲生物分析測試服務市場 - 收入和 2030 年預測 - 按服務分類

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按服務分類）（%）
  • 藥物動力學
  • 生物標記
  • 免疫原性
  • 病毒學檢測
  • 基於細胞的檢測
  • 其他

第 8 章：歐洲生物分析測試服務市場 - 收入和 2030 年預測 - 按疾病適應症

  • 概述
  • 2022 年和 2030 年按疾病適應症分類的生物分析測試服務市場收入佔有率 (%)
  • 心血管
  • 神經系統疾病
  • 自體免疫疾病
  • 呼吸疾病
  • 代謝紊亂
  • 腫瘤學
  • 性健康
  • 骨病
  • 其他

第 9 章：歐洲生物分析測試服務市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按最終用戶分類）（%）
  • 製藥和生物製藥公司
  • 合約研究組織（CRO）
  • 合約開發與製造組織 (CDMO)
  • 其他

第 10 章：歐洲生物分析測試服務市場 - 國家分析

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 11 章：生物分析測試服務市場產業格局

  • 概述
  • 生物分析測試服務市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc

第 13 章：附錄

Product Code: BMIRE00029558

The Europe bioanalytical testing services market was valued at US$ 1,374.48 million in 2022 and is expected to reach US$ 2,956.96 million by 2030; it is estimated to grow at a CAGR of 10.0% from 2022 to 2030.

High Demand for Analytical Testing of Biosimilars and Biologics Fuel the Europe Bioanalytical Testing Services Market

Biologics are among the most promising therapeutic areas important in the pharmaceutical market. The rising number of cases of chronic diseases such as inflammatory bowel diseases, cancer, and rheumatoid arthritis propels the demand for biologics. However, the high cost of biologics' has redirected the focus of drug developers and healthcare stakeholders toward biosimilars in recent years. Additionally, the imminent expiry of the patents and exclusivity periods of biologics have also created opportunities for the development of biosimilars. According to McKinsey & Co., ~19 high-volume biologics would lose exclusivity by 2025. Additionally, 39 more high-volume biologics are expected to lose patent protection between 2026 and 2032, with more biologics likely to follow. The Association for Accessible Medicines (AAM) expects a ~25% price drop on branded biologics on average after the launch of biosimilars because average biosimilar sales prices are ~50% lower than the original branded biologics.

The anticipated rise in biosimilar R&D would boost the demand for related bioanalytical testing services-compatibility studies for biosimilars, stability testing, product release testing, and biosimilar protein analysis-to reduce the risks involved with medication development. Thus, the rise in demand for analytical testing of biosimilars is boosting the growth of the bioanalytical testing services market.

Europe Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region occupies a significant position in the global bioanalytical testing services market. The European bioanalytical testing services market is expected to witness significant growth during the forecast period due to the strong manufacturing capabilities in the pharmaceutical, biopharmaceutical, and biotechnological industries, and the presence of leading bioanalytical testing service providers in different European countries.

Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Europe Bioanalytical Testing Services Market Segmentation

The Europe bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Europe bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Europe bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Europe bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Europe bioanalytical testing services market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, KCAS Bioanalytical and Biomarker Services LLC, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Europe bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis

5. Europe Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Europe Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
      • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 In-Vivo Virology Testing
      • 7.6.3.1 Overview
      • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Respiratory Diseases
    • 8.6.1 Overview
    • 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Metabolic Disorders
    • 8.7.1 Overview
    • 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Oncology
    • 8.8.1 Overview
    • 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Sexual Health
    • 8.9.1 Overview
    • 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Bone Disease
    • 8.10.1 Overview
    • 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development and Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Bioanalytical Testing Services Market - Country Analysis

  • 10.1 Europe Bioanalytical Testing Services Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 Europe Bioanalytical Testing Services Market by Country
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Germany Bioanalytical Testing Services Market, by Services
        • 10.1.1.2.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.2.4 Germany Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.2.5 Germany Bioanalytical Testing Services Market, by End User
      • 10.1.1.3 UK
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 UK Bioanalytical Testing Services Market, by Services
        • 10.1.1.3.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.3.4 UK Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.3.5 UK Bioanalytical Testing Services Market, by End User
      • 10.1.1.4 France
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 France Bioanalytical Testing Services Market, by Services
        • 10.1.1.4.3.1 France Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.4.4 France Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.4.5 France Bioanalytical Testing Services Market, by End User
      • 10.1.1.5 Italy
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Italy Bioanalytical Testing Services Market, by Services
        • 10.1.1.5.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.5.4 Italy Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.5.5 Italy Bioanalytical Testing Services Market, by End User
      • 10.1.1.6 Spain
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 Spain Bioanalytical Testing Services Market, by Services
        • 10.1.1.6.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.6.4 Spain Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.6.5 Spain Bioanalytical Testing Services Market, by End User
      • 10.1.1.7 Rest of Europe
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Europe Bioanalytical Testing Services Market, by Services
        • 10.1.1.7.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.7.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.7.5 Rest of Europe Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 SGS SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pharmaron Beijing Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Element Materials Technology Group Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Charles River Laboratories International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Eurofins Scientific SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Labcorp Drug Development Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Syneos Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 KCAS Bioanalytical and Biomarker Services LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 ICON Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Intertek Group Plc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Bioanalytical Testing Services Market Segmentation
  • Table 2. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 3. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 5. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 6. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 15. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 16. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 17. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 18. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 19. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 20. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 21. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 23. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 24. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 25. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 27. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 28. Glossary of Terms, Europe Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. Europe Bioanalytical Testing Services Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Europe Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
  • Figure 31. Europe Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 32. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Growth Strategies in the Bioanalytical Testing Services Market